Oxford Biomaterials Limited
Like Newrotex, Oxford Biomaterials is based in Oxford Science Park. Newrotex Co-founder Prof Fritz Vollrath is a former Director of the company, while our COO Dr Robyn Plowright was previously the R&D Manager at the company.
Oxford Biomaterials aims to establish a global market for its silk biomaterials, and its proprietary Spidrex platform is used in a wide range of medical devices. Laboratory research shows that Spidrex nerve conduits are effective for guided nerve growth.